Wegovy is a prescription weight loss treatment that contains the active ingredient semaglutide, belonging to a group of medications called GLP-1 inhibitors.¹
It works by mimicking a naturally occurring hormone in the body called GLP-1, stimulating nerve receptors in the brain that control appetite, so you feel less hungry and have fewer cravings.¹
Additionally, it stimulates the release of insulin from pancreatic beta cells, as GLP-1 is present in both the pancreas and the brain.³ Implementing behavioural change strategies alongside the treatment is known to be an effective method for weight loss.2
In a major clinical trial, participants who received the full therapeutic dose of 2.4 mg per week lost an average of 15% of their body weight over 68 weeks, compared to just 2.4% in those who received a placebo. This level of weight loss is significantly greater than what’s typically seen with lifestyle changes alone.1
The study found a clear dose-response relationship, whereby lower doses of semaglutide (such as 1.0 mg or 1.7 mg) led to less weight loss, while the 2.4 mg dose produced the most substantial effects.1

A revolutionary weekly injection that aids in weight loss and blood sugar control by mimicking natural hormones. Users report significant weight reduction and improved metabolic health.
We will connect you with a Neuva Health consultant to review your health profile and provide a prescription if necessary.